CurrentEndo coverage · page 5 of 5

Diabetes & Metabolism

Briefs 161–190 of 190 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes & Metabolism

All coverage, newest first

Diabetes Metab1 Aug 2023
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes
Cohort studyT2D & other
Diabetes Metab12 Jul 2023
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study
Cohort studyBone & mineral
Diabetes Metab17 Jun 2023
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes
Cohort studyDiabetes in pregnancy
Diabetes Metab6 Jun 2023
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes
Cohort studyT2D & other
Diabetes Metab2 Jun 2023
A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis
Cohort studyT2D & other
Diabetes Metab25 May 2023
Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study
Cohort studyComplications
Diabetes Metab7 Apr 2023
Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study
Cohort studyDiabetes in pregnancy
Diabetes Metab25 Mar 2023
Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in Taiwan
Cohort studyT1D
Diabetes Metab16 Mar 2023
Association between glycemic status and age-related macular degeneration: A nationwide population-based cohort study
Cohort studyT2D & other
Diabetes Metab15 Mar 2023
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
Cohort studyT2D & other
Diabetes Metab9 Mar 2023
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Randomized controlled trialT2D & other
Diabetes Metab1 Feb 2023
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients
Cohort studyComplications
Diabetes Metab28 Jan 2023
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study
Cohort studyComplications
Diabetes Metab25 Jan 2023
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months
Cohort studyT2D & other
Diabetes Metab17 Jan 2023
Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes
Cohort studyT2D & other
Diabetes Metab17 Jan 2023
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study
Cohort studyT1D
Diabetes Metab12 Jan 2023
Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate
Cohort studyComplications
Diabetes Metab3 Jan 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Cohort studyT2D & other
Diabetes Metab28 Dec 2022
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes
Cohort studyComplications
Diabetes Metab20 Dec 2022
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan
Cohort studyLipids & liver
Diabetes Metab6 Dec 2022
Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population
Cohort studyLipids & liver
Diabetes Metab29 Nov 2022
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
Cohort studyComplications
Diabetes Metab20 Nov 2022
Clinical relevance of coronary risk classification and reclassification with coronary artery calcium score in asymptomatic people living with diabetes. An observational study
Cohort studyT2D & other
Diabetes Metab15 Nov 2022
Physical activity and diabetes mortality in people with type 2 diabetes: a prospective cohort study of 0.5 million US people
Cohort studyT2D & other
Diabetes Metab15 Nov 2022
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease
Cohort studyComplications
Diabetes Metab15 Nov 2022
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes
Cross-sectional studyObesity
Diabetes Metab22 Oct 2022
Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis
Cohort studyLipids & liver
Diabetes Metab1 Oct 2022
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring
Cohort studyT1D
Diabetes Metab26 Sep 2022
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study
Cohort studyT2D & other
Diabetes Metab25 Sep 2022
Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus
Cohort studyT2D & other

All 190 Briefs in ExploreShowing Briefs 161–190 of 190, newest first